HAS is characterized by a histological resemblance to hepatocellular carcinoma (HCC); in addition to morphological confirmation, HAS can be confirmed by several immunohistochemical markers, such as AFP, GPC-3, SALL4, and Hap-Par 1 [4, 5]. Here, GPC3 is linked to hepatocellular carcinoma.